ATE477339T1 - Zusammensetzungen und verfahren zur vorhersage des ausgangs einer behandlung - Google Patents
Zusammensetzungen und verfahren zur vorhersage des ausgangs einer behandlungInfo
- Publication number
- ATE477339T1 ATE477339T1 AT06742440T AT06742440T ATE477339T1 AT E477339 T1 ATE477339 T1 AT E477339T1 AT 06742440 T AT06742440 T AT 06742440T AT 06742440 T AT06742440 T AT 06742440T AT E477339 T1 ATE477339 T1 AT E477339T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- markers
- treatment
- outcome
- predicting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Processing Of Solid Wastes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68607005P | 2005-05-31 | 2005-05-31 | |
| PCT/DK2006/000300 WO2006128463A2 (en) | 2005-05-31 | 2006-05-30 | Compositions and methods for predicting outcome of treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE477339T1 true ATE477339T1 (de) | 2010-08-15 |
Family
ID=35809661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06742440T ATE477339T1 (de) | 2005-05-31 | 2006-05-30 | Zusammensetzungen und verfahren zur vorhersage des ausgangs einer behandlung |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8679746B2 (de) |
| EP (1) | EP1885878B1 (de) |
| AT (1) | ATE477339T1 (de) |
| DE (1) | DE602006016106D1 (de) |
| ES (1) | ES2350648T3 (de) |
| WO (1) | WO2006128463A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110318732A1 (en) * | 2008-05-28 | 2011-12-29 | Singer Robert H | Prediction of chemotherapeutic response via single-cell profiling of transcription site activation |
| WO2010028288A2 (en) | 2008-09-05 | 2010-03-11 | Aueon, Inc. | Methods for stratifying and annotating cancer drug treatment options |
| CA2763321C (en) * | 2009-05-29 | 2018-10-16 | Ventana Medical Systems, Inc. | Methods of scoring gene copy number in a biological sample using in situ hybridization |
| EP2619329B1 (de) | 2010-09-24 | 2019-05-22 | The Board of Trustees of The Leland Stanford Junior University | Direkte erfassung, amplifikation und sequenzierung einer ziel-dna unter verwendung immobilisierter primer |
| US9556473B2 (en) * | 2011-02-15 | 2017-01-31 | Leica Biosystems Newcastle Ltd | Methods for identifying nucleic acid sequences |
| JP6841609B2 (ja) | 2015-07-10 | 2021-03-10 | 3スキャン インコーポレイテッド | 組織学的染色の空間的多重化 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2479446C (en) | 2003-08-28 | 2013-05-07 | F.Hoffmann-La Roche Ag | Correlation of the ratio of tp and dpd mrna expression levels in colorectal cancer with disease-free survival in 5-fu treated patients |
-
2006
- 2006-05-30 AT AT06742440T patent/ATE477339T1/de not_active IP Right Cessation
- 2006-05-30 WO PCT/DK2006/000300 patent/WO2006128463A2/en not_active Ceased
- 2006-05-30 ES ES06742440T patent/ES2350648T3/es active Active
- 2006-05-30 US US11/915,970 patent/US8679746B2/en active Active
- 2006-05-30 EP EP06742440A patent/EP1885878B1/de not_active Not-in-force
- 2006-05-30 DE DE602006016106T patent/DE602006016106D1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006128463A3 (en) | 2007-02-15 |
| ES2350648T3 (es) | 2011-01-25 |
| EP1885878B1 (de) | 2010-08-11 |
| US8679746B2 (en) | 2014-03-25 |
| EP1885878A2 (de) | 2008-02-13 |
| WO2006128463A2 (en) | 2006-12-07 |
| DE602006016106D1 (de) | 2010-09-23 |
| US20090042187A1 (en) | 2009-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2125855A4 (de) | Verfahren und zusammensetzungen zur behandlung von krebs und anderen krankheiten | |
| EP1945754A4 (de) | Zusammensetzungen und verfahren zur behandlung und diagnostizierung von krebs | |
| ATE497496T1 (de) | 2,4-pyridimediamon-derivate als hemmer von jak- kinasen zur behandlung von autoimmunerkrankungen | |
| EP1765391A4 (de) | Bakterielle zusammensetzungen zur behandlung von krebs | |
| ATE523525T1 (de) | Anti-tumorassoziiertes antigen tat10772 zum nachweis und behandlung von krebs | |
| IL194843A0 (en) | Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors | |
| BRPI0519424A2 (pt) | composiÇÕes e mÉtodos para tratamento de distérbios de proliferaÇço celular | |
| WO2008008430A3 (en) | Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases | |
| DE602006018057D1 (de) | Substituierte chinolone und verwendungsverfahren | |
| MX2009006466A (es) | Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina. | |
| ZA200702322B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| EP2141989A4 (de) | Zusammensetzungen und verfahren zur vorbeugung und behandlung von suchtkrankheiten | |
| EA201001143A1 (ru) | Активаторы прокаспаз "исполнителей" 3, 6 и 7 | |
| EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
| ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| WO2008088860A3 (en) | Polymorphisms in the egfr pathway as markers for cancer treatment | |
| WO2006015079A3 (en) | Erm family binding agents and their use in diagnosis and treatment of proliferative conditions | |
| TW200626900A (en) | Wnt proteins and detection and treatment of cancer | |
| DE602004021435D1 (de) | Injizierbare zusammensetzung zur behandlung von krebs | |
| TNSN06321A1 (en) | Beta-carbolines useful for treating inflammatory disease | |
| ATE477339T1 (de) | Zusammensetzungen und verfahren zur vorhersage des ausgangs einer behandlung | |
| IL185900A0 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| EP1755581A4 (de) | Verfahren und zusammensetzungen zur behandlung von myokardialen erkrankungen | |
| ATE522625T1 (de) | Verfahren und zusammensetzungen zur diagnose und behandlung von lungenkrebs mittels pdgfra-, kit- oder kdg-gen als genmarker | |
| EP1720410A4 (de) | Zusammensetzungen und verfahren für die behandlung und klinische remission von schuppenflechte |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |